OrthoPediatrics Corp. (KIDS)
| Market Cap | 1.28B |
| Revenue (ttm) | 89.29M |
| Net Income (ttm) | -32.69M |
| Shares Out | 19.28M |
| EPS (ttm) | -1.70 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 17,201 |
| Open | 64.64 |
| Previous Close | 64.83 |
| Day's Range | 64.56 - 65.56 |
| 52-Week Range | 38.01 - 72.50 |
| Beta | 0.72 |
| Analysts | Buy |
| Price Target | 77.50 (+18.7%) |
| Est. Earnings Date | Nov 3, 2021 |
About KIDS
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking can...
Financial Performance
In 2020, KIDS's revenue was $71.08 million, a decrease of -2.03% compared to the previous year's $72.55 million. Losses were -$32.94 million, 139.9% more than in 2019.
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for KIDS stock is "Buy." The 12-month stock price forecast is 77.50, which is an increase of 18.71% from the latest price.
News
OrthoPediatrics Corp. Recognized in COVID Stops Here Campaign
WARSAW, Ind., Oct. 18, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, ...
OrthoPediatrics Corp. Announces Preliminary Unaudited Revenue for the Third Quarter 2021 and Reiterates 2021 Revenue ...
WARSAW, Indiana, Oct. 13, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedic...
OrthoPediatrics Corp. Continues Support of Autumn Surgical Society Meetings
WARSAW, Ind., Oct. 04, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, ...
OrthoPediatrics, SeaSpine Ink Distribution Pact For Image Guidance System
OrthoPediatrics Corp (NASDAQ: KIDS) entered into a distribution agreement with SeaSpine Holdings Corporation (NASDAQ: SPNE) for the 7D Surgical FLASH Navigation platform. Under the 5-year exclusive agr...
OrthoPediatrics Announces Entry into a Distribution Agreement with SeaSpine to Exclusively Distribute the 7D Surgical...
Enables OrthoPediatrics to Further Address Full Patient Continuum of Care for Pediatric Orthopedic Surgeons with Market-Leading, Radiation-Free Navigation Technology Enables OrthoPediatrics to Further A...
Orthopediatrics Insider Sold Over $357.50 Thousand In Company Stock
Fred Hite, Coo And Cfo at Orthopediatrics (NASDAQ:KIDS), made a large insider sell on September 2, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Com...
OrthoPediatrics (KIDS) Reports Q2 Loss, Tops Revenue Estimates
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of 47.62% and 10.60%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
OrthoPediatrics Corp. Reports Second Quarter 2021 Financial Results
Second Quarter 2021 Revenue Increased 96% Year-over-Year with Continued Strong Domestic Growth Second Quarter 2021 Revenue Increased 96% Year-over-Year with Continued Strong Domestic Growth
OrthoPediatrics Corp. and Mighty Oak Medical Extend Exclusive Partnership for FIREFLY Technology in Pediatric Orthope...
WARSAW, Ind., Aug. 04, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), and Mighty Oak Medical, Inc. are pleased to announce the continuation of their ...
Will OrthoPediatrics (KIDS) Report Negative Earnings Next Week? What You Should Know
OrthoPediatrics (KIDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OrthoPediatrics Corp. Maintains its Diamond Sponsorship for 31st Annual Baltimore Limb Deformity Course (“BLDC”)
WARSAW, Ind., July 29, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, ...
OrthoPediatrics Corp. to Report Second Quarter 2021 Financial Results on August 5, 2021
WARSAW, Ind., July 22, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today t...
OrthoPediatrics Corp. Announces Launch of Next Generation Cannulated Screw System
WARSAW, Ind., June 10, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today t...
OrthoPediatrics Corp. to Present at the 2021 JMP Securities Life Sciences Conference
WARSAW, Ind., June 09, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, ...
OrthoPediatrics Corp. Completes Senior Leadership Transition with Appointment of David Bailey as Chief Executive Officer
WARSAW, Ind., June 03, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced t...
OrthoPediatrics Corp. Launches RESPONSE™ Neuromuscular Scoliosis System
WARSAW, Ind., May 28, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced the laun...
OrthoPediatrics Corp. Continues Double Diamond Sponsorship for 2021 POSNA Meeting
WARSAW, Ind., May 17, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, has continued the ...
OrthoPediatrics (KIDS) Moves 9.1% Higher: Will This Strength Last?
OrthoPediatrics (KIDS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down t...
OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of -8.70% and 8.50%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
OrthoPediatrics (KIDS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
OrthoPediatrics (KIDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OrthoPediatrics Corp. to Participate in the 7th Annual Truist Securities 2021 Life Sciences Summit
WARSAW, Ind., April 22, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, ...
OrthoPediatrics Corp. to Report First Quarter 2021 Financial Results on May 5, 2021
Conference Call to Discuss Results on May 6, 2021 at 8:00 a.m. ET Conference Call to Discuss Results on May 6, 2021 at 8:00 a.m. ET
OrthoPediatrics Corp. to Participate in the 20th Annual Needham Virtual Healthcare Conference
WARSAW, Ind., March 31, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, ...
OrthoPediatrics Surpasses Milestones of 500 Scoliosis Correction Cases Worldwide and Nine-Years of Clinical Experienc...
The Internal Brace Option™ is a viable alternative for treating progressive moderate scoliosis in adolescents and a game-changing treatment option for medical providers and patients to consider The Inte...